Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arbidol hydrochloride versus oseltamivir for uncomplicated influenza in adolescents and adults
ChiCTR2400080762Phase 4Completed
- Sponsor
- Beijing Ditan Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of umifenovir and oseltamivir in influenza (2 arms), sponsored by Beijing Ditan Hospital. Primary endpoint: Duration of relief of flu symptoms. Started Feb 2024; status: completed.
02
Drugs
umifenoviroseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR2400080762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080762.